Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient Communication

News
Video

The discussion focuses on monitoring and managing neurologic toxicities like ICANS in CAR-T therapy, highlighting tools for early detection, effective management strategies, and approaches to communicating risks with patients and caregivers.

Video content above is prompted by the following:

  • Neurologic toxicities, such as ICANS, pose unique challenges. How do you approach monitoring and management of these events in your practice?
  • What tools or assessment methods help you identify early signs of neurotoxicity?
  • How do you communicate these risks to patients and their caregivers?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Related Content